Journal of Mahatma Gandhi University of Medical Sciences and Technology

Register      Login

VOLUME 5 , ISSUE 1 ( January-April, 2020 ) > List of Articles

Original Article

Association of Fine Needle Aspiration Cytology with Histopathology and Thyroid-stimulating Hormone in the Diagnosis of Thyroid Lesions

Akanksha Gupta, Surabhi Tyagi, Mohan Lal Yadav

Keywords : FNAC sensitivity, Histopathology, Specificity, Thyroid gland, Thyroid-stimulating hormone,Fine needle aspiration cytology

Citation Information : Gupta A, Tyagi S, Yadav ML. Association of Fine Needle Aspiration Cytology with Histopathology and Thyroid-stimulating Hormone in the Diagnosis of Thyroid Lesions. J Mahatma Gandhi Univ Med Sci Tech 2020; 5 (1):9-15.

DOI: 10.5005/jp-journals-10057-0121

License: CC BY-NC 4.0

Published Online: 15-02-2021

Copyright Statement:  Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction: Diseases of the thyroid gland include both benign and malignant conditions. Benign conditions include goiter, thyroiditis, and follicular adenoma. Malignant conditions include follicular, papillary, medullary, anaplastic carcinoma. Fine needle aspiration cytology (FNAC) of the thyroid gland is the first-line diagnostic test for the evaluation of diffuse thyroid lesions as well as thyroid nodules. The main purpose it serves is in confirming benign lesions and avoiding surgery in benign lesions. The most common investigations, a patient of thyroid lesion undergoes, include thyroid assay and FNAC. Materials and methods: This prospective hospital-based observational study includes all patients from January 2019 to June 2019, with thyroid lesions who will undergo FNAC, excisional biopsy of thyroid, and serum thyroid-stimulating hormone (TSH) level. In the department of pathology Mahatma Gandhi Medical College and Hospital, Sitapura, Jaipur (Rajasthan). Results: The study was undertaken on 60 patients with clinically thyroid lesions during a period of approximately January 2019 to June 2019. Most thyroid lesions in our study were benign (62%). Out of 39 cytological benign lesions, 2 on histopathological follow-up were found malignant, i.e., 5%, and the rest 37 cases were found benign, i.e., 95%. All of the 16 cytological malignant lesions on histopathological follow-up were found malignant, i.e., 100%. All of the five cytologically suspicious for malignancy were found malignant on histopathological follow-up, i.e., 100%. In the present study, maximum number of benign cases, i.e., 14 cases (38%), were found to have serum TSH levels in the range of 0.40–1.39 μIU/mL, and the maximum number of malignant, i.e., 13 cases (53%), were found TSH in the range of 5 μIU/mL or more on the basis histopathological diagnosis. In the present study, maximum number of benign, i.e., 15 cases (38.4%), were found to have TSH in the range of 0.40–1.39 μIU/mL, and a maximum number of malignant cases, i.e., 12 (57.14%), were found in the TSH range of 5 μIU/mL or more on the basis cytology diagnosis. Conclusion: There is a significant association between TSH and malignancy, TSH within high normal range and higher serum concentration TSH both are associated with a higher risk of thyroid malignancy.


PDF Share
  1. Gul K, Ozdemir D, Ayten Oguz AD. Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin? Int J Bas Clin Endocrinol 2010;37(2):253–260. DOI: 10.1007/s12020-010-9316-6.
  2. Fiore E, Rago T, Provenzale MA, et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 2009;16(4):1251–1260. DOI: 10.1677/ERC-09-0036.
  3. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87(2):489–499. DOI: 10.1210/jcem.87.2.8182.
  4. Gopalakrishnan Unnikrishnan A, Menon UV. Thyroid disorders in India: an epidemiological perspective. Indian J Endocrinol Metab 2011;15(Suppl 2):S78–S81. DOI: 10.4103/2230-8210.83329.
  5. Haymart MR, Repplinger DJ, Leverson GE, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metabol 2007;93(3):809–814. DOI: 10.1210/jc.2007-2215.
  6. Sinna EA, Ezzat N. Diagnostic accuracy of fine needle aspiration cytology in thyroid lesions. J Egypt Natl Canc Inst 2012;24(2):63–70. DOI: 10.1016/j.jnci.2012.01.001.
  7. Tseng C-E, Wei C-K, Kuo C-S, et al. Fine needle aspiration cytology of thyroid nodules: evaluation of diagnostic accuracy. Tzu Chi Med J 2008;20(4):296–303. DOI: 10.1016/S1016-3190(08)60054-3.
  8. Greenspan FS. The role of fine-needle aspiration biopsy in the management of palpable thyroid nodules. Am J Clin Pathol 1997;108(4 Suppl. 1):S26–S30.
  9. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16(2):109–142. DOI: 10.1089/thy.2006.16.109.
  10. Arul P, Akshatha C, Masilamani. S. A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: an institutional experience. Biomed J 2016;38(6):517–522. DOI: 10.1016/j.bj.2015.08.001.
  11. Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 2017;27(11):1341–1346. DOI: 10.1089/thy.2017.0500.
  12. Feld S. Clinical Practice Guidelines for the Diagnosis and Management of thyroid Nodules. The American Association of Clinical Endocrinologists and the American College of Endocrinology, 1996.
  13. Bhojani K, Patel C, Dhruva G. Histopathological examination of thyroid lesions with cytological and hormonal correlation. Med Pulse Int J Pathol 2019;9(3):126–129. DOI: 10.26611/105938.
  14. Tabaqchali MA, Hanson JM, Johnson SJ, et al. Thyroid aspiration cytology in Newcastle: a six year cytology/histology correlation study. Ann R Coll Surg Engl 2000;82(3):149.
  15. Afroze N, Kayani N, Husain SH. Role of fine needle aspiration cytology in the diagnosis of palpable thyroid lesion. Indian J Pathol Microbiol 2002;45(3):241–246.
  16. Handa U, Garg S, Mohan H, et al. Role of fine needle aspiration cytology in diagnosis and management of thyroid lesions: A study on 434 patients. J Cytol 2008;25(1):13–17. DOI: 10.4103/0970-9371.40652.
  17. Gupta M, Gupta S, Gupta VB. Correlation of fine needle aspiration cytology with histopathology in the diagnosis of solitary thyroid nodule. J Thyr Res 2010;2010:379051. DOI: 10.4061/2010/379051.
  18. Sengupta A, Pal R, Kar S, et al. Fine needle aspiration cytology as the primary diagnostic tool in thyroid enlargement. J Nat Sci Biol Med 2011;2(1):113. DOI: 10.4103/0976-9668.82308.
  19. El Hag IA, Kollur SM, Chiedozi LC. The role of FNA in the initial management of thyroid lesions: 7-year experience in a district general hospital. Cytopathology 2003;14(3):126–130. DOI: 10.1046/j.1365-2303.2003.00053.x.
  20. Sangalli G, Serio G, Zampatti C, et al. Fine needle aspiration cytology of the thyroid: a comparison of 5469 cytological and final histological diagnoses. Cytopathology 2006;17(5):245–250. DOI: 10.1111/j.1365-2303.2006.00335.x.
  21. Aravinthan T, Banagala AS, Gamage KJ. Use of fine needle aspiration cytology on thyroid lumps. Galle Med J 2007;12(1):25–29. DOI: 10.4038/gmj.v12i1.1081.
  22. Mandal S, Barman D, Mukherjee A, et al. Fine needle aspiration cytology of thyroid nodules – evaluation of its role in diagnosis and management. J Indian Med Assoc 2011;109:258–261.
  23. Bamanikar S, Soraisham P, Jadhav S, et al. Cyto-histology and clinical correlation of thyroid gland lesions: a 3 year study in a tertiary hospital. Clin Cancer Investig J 2014;3(3):208–212. DOI: 10.4103/2278-0513.132112.
  24. Nandedkar SS, Dixit M, Malukani K, et al. Evaluation of thyroid lesions by fine-needle aspiration cytology according to Bethesda system and its histopathological correlation. Int J Appl Basic Med Res 2018;8(2):76. DOI: 10.4103/ijabmr.IJABMR_169_17.
  25. Choi JS, Nam CM, Kim EK, et al. Evaluation of serum thyroid-stimulating hormone as indicator for fine-needle aspiration in patients with thyroid nodules. Head Neck 2015;37(4):498–504. DOI: 10.1002/hed.23616.
  26. Sathyanarayana BA, Ramachandra J, Sinha SK, et al. Clinical study of thyroid malignacies and the role of serum TSH in predicting malignancies. Gangtie 2013;2:8386–8392.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.